Stealth BioTherapeutics Company

Stealth is a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction. Mitochondria, found in nearly every cell in the body, are the body's main source of energy production and are critical for normal organ function.

Founded Date: 2007
Technology: Geroscience
Investor Type: Company
Funding Status: IPO
Total Funding: $120M
Employee Number: 101-250
Headquarters: Cayman Islands
Investors Number: 8
Last Funding Type: Post-IPO Equity
Estimated Revenue: $10M to $50M
Number Of Exists: Post-IPO Equity
Industry: Oxidative Phosphorylation